Halloween has come and gone in the US, and Americans are now gearing up for Thanksgiving and Christmas. But before the holiday season could get underway, the country went through a major political event with far-reaching implications: the midterm elections.As…
HOME > BUSINESS
BUSINESS
- Nippon Zoki Eyes Alzheimer’s as New R&D Focus, First Up Is Label Expansion for Pain Med
October 13, 2020
- Samsca IV Prodrug Shows Non-Inferiority to Oral Agent
October 13, 2020
- Nichi-Iko, Sanofi in Authorized Generic Pact for ComPlavin
October 13, 2020
- Keytruda Filed for Triple Negative Breast Cancer in Japan: MSD
October 13, 2020
- Kyorin Transfers IP Rights for Novel Immunomodulator to Irish Firm
October 13, 2020
- Despite Price Cuts, Dupixent Netting Bullish Sales to Become Sanofi’s New Flagship
October 12, 2020
- Kissei Out-Licenses Parkinson’s Med to Hong Kong’s Affamed
October 12, 2020
- Canagliflozin Approved in Indonesia: Mitsubishi Tanabe
October 12, 2020
- Takeda-Led Alliance Kicks Off Global PIII for COVID-19 Plasma Therapy
October 12, 2020
- Takeda, US Arrowhead Join Forces on Intractable Liver Disease Therapy
October 12, 2020
- Sumitomo Chemical, Sumitomo Dainippon Launch JV for Cell Therapy CDMO
October 12, 2020
- Maruho Taps Meiji as Copromotion Partner for Amenalief
October 9, 2020
- Towa Plans to Start Full-Scale Continuous Manufacturing in FY2024, Aiming at Whole Automated Process
October 9, 2020
- University of Tokyo, Eisai Link Arms for Research on Targeted Protein Degradation Technology
October 9, 2020
- AnGes Out-Licenses Collategene to Turkish Pharma
October 9, 2020
- Sumitomo Dainippon Rejigs Organization to Become Top CNS Player in Japan, Sets 50 Billion Yen Near-Term Goal
October 8, 2020
- Japan Ethical Drug Sales Dip 9.0% in August: Crecon
October 8, 2020
- Pfizer, Merck Biopharma to End Xalkori Copromotion in Japan
October 8, 2020
- Fujifilm to Expand Viral Vector CDMO Biz to Europe
October 8, 2020
- Hisamitsu Initiates Japan PIII of Palmar Hyperhidrosis Drug, Aims at Filing in FY2022
October 8, 2020
